CHARCO NEUROTECH LTD

Active United Kingdom

Manufacture of medical and dental instruments and supplies

17 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesResearch and experimental development on social sciences and humanities
C

CHARCO NEUROTECH LTD

Manufacture of medical and dental instruments and supplies

Founded 3 Jun 2019 Active United Kingdom 17 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesResearch and experimental development on social sciences and humanities

Previous Company Names

THEMOMENT LTD 3 Jun 2019 — 18 Mar 2020
Accounts Submitted 28 Jul 2025 Next due 30 Nov 2026 5 months remaining
Confirmation Submitted 12 Jun 2025 Next due 15 Jun 2026 10 days remaining
Net assets £3M £2M 2024 year on year
Total assets £3M £2M 2024 year on year
Total Liabilities £244K £222K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Website

www.example.com

Full company profile for CHARCO NEUROTECH LTD (12028625), an active life sciences and medical technology company based in United Kingdom. Incorporated 3 Jun 2019. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Mar → 28 Feb 2025
Type total-exemption-full
Next accounts 28 Feb 2026
Due by 30 Nov 2026 5 months remaining

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£2.39M

Decreased by £2.12M (-47%)

Net Assets

£3.19M

Decreased by £1.79M (-36%)

Total Liabilities

£243.87k

Decreased by £221.73k (-48%)

Turnover

N/A

Employees

17

Decreased by 5 (-23%)

Debt Ratio

7%

Decreased by 2 (-22%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
28 Feb Year End
2024
29 Feb Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Investor 4Jan 2019Unknown/Other
Investor 9Mar 2020Accelerator/Incubator
Investor 3Feb 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 3,807,046 Shares £17.81m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Jun 2024392,857£550k£1.4
27 Jun 2024392,857£550k£1.4
31 Jan 202414,285£20k£1.4
31 Jan 20247,142£10k£1.4
31 Jan 20247,142£10k£1.4

Officers

Officers

1 active 2 resigned
Status
Parkwalk Advisors LtdCorporate-directorUnited KingdomUnknown29 Sept 2021Active

Shareholders

Shareholders (52)

Mnl (parkwalk) Nominees Limited
24.9%
1,924,161
The University Of Tokyo Edge Capital Partners
16.4%
1,272,038

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased
Active
Notified 20 Feb 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent As Firm,voting Rights 25 To 50 Percent As Firm

Soo Min Jung

South Korean

Active
Notified 3 Jun 2019
Residence England
DOB November 1987
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Floyd Pierres

Ceased 4 Sept 2020

Ceased

Group Structure

Group Structure

CHARCO NEUROTECH LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 May 2026CapitalCapital Name Of Class Of Shares
27 Apr 2026IncorporationMemorandum Articles
27 Apr 2026ResolutionResolutions
15 Apr 2026CapitalAllotment of shares (GBP 86.78449) on 9 Apr 2026
10 Apr 2026OfficersTermination of Hiroaki Kobayashi as director on 30 Mar 2026
3 May 2026 Capital

Capital Name Of Class Of Shares

27 Apr 2026 Incorporation

Memorandum Articles

27 Apr 2026 Resolution

Resolutions

15 Apr 2026 Capital

Allotment of shares (GBP 86.78449) on 9 Apr 2026

10 Apr 2026 Officers

Termination of Hiroaki Kobayashi as director on 30 Mar 2026

Recent Activity

Latest Activity

Capital Name Of Class Of Shares

1 months ago on 3 May 2026

Memorandum Articles

1 months ago on 27 Apr 2026

Resolutions

1 months ago on 27 Apr 2026

Allotment of shares (GBP 86.78449) on 9 Apr 2026

1 months ago on 15 Apr 2026

Termination of Hiroaki Kobayashi as director on 30 Mar 2026

1 months ago on 10 Apr 2026